Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

6

Revenue 2017

Johnson & Johnson

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Johnson & Johnson's 2013 sales performance.

Johnson & Johnson

AbbVie reports more solid data for would-be psoriasis blockbuster

AbbVie reports more solid data for would-be psoriasis blockbuster

A pair of phase III trials pitting risankizumab against Johnson &Johnson’s older IL-12/IL-23 inhibitor Stelara (ustekinumab) - reported at the American Academy of Dermatology meeting in Chicago over

Lilly drops Hanmi-partnered arthritis drug

Lilly drops Hanmi-partnered arthritis drug The first BTK inhibitor to reach the market was Johnson &Johnson (J&J) and Pharmacyclics' Imbruvica (ibrutinib), but this has been introduced initially for blood cancers including chronic lymphocytic leukaemia (CLL)

J&J’s Erleada first US drug for non-metastatic prostate cancer

J&J’s Erleada first US drug for non-metastatic prostate cancer Johnson &Johnson is celebrating a much earlier-than-expected FDA approval for Erlea, which becomes the first drug in the US for non-metastatic, castration-resistant prostate cancer (CRPC).

J&J extends its JLABS incubator scheme to Europe

J&J extends its JLABS incubator scheme to Europe Johnson &Johnson has been talking up the benefits of its JLABS incubator strategy for R&D collaboration for some time, and is now setting up a unit in Belgium to debut

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018
...

Infographics